Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Anemia

  Free Subscription


Articles published in Leukemia

Retrieve available abstracts of 34 articles:
HTML format



Single Articles


    June 2024
  1. WAKAMATSU M, Muramatsu H, Sato H, Ishikawa M, et al
    Integrated proteogenomic analysis for inherited bone marrow failure syndrome.
    Leukemia. 2024;38:1256-1265.
    PubMed     Abstract available


    January 2024
  2. DUARTE TL, Lopes M, Oliveira M, Santos AG, et al
    Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice.
    Leukemia. 2024;38:96-108.
    PubMed     Abstract available


  3. LI C, Xu J, Luo W, Liao D, et al
    Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma.
    Leukemia. 2024;38:149-159.
    PubMed     Abstract available


    December 2023
  4. LIU Y, Karlsson S
    Correction: Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia.
    Leukemia. 2023 Dec 13. doi: 10.1038/s41375-023-02101.
    PubMed    


    November 2023
  5. LIU Y, Karlsson S
    Perspectives of current understanding and therapeutics of Diamond-Blackan anemia.
    Leukemia. 2023 Nov 16. doi: 10.1038/s41375-023-02082.
    PubMed     Abstract available


  6. BAUER K, Machherndl-Spandl S, Kazianka L, Sadovnik I, et al
    CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
    Leukemia. 2023;37:2250-2260.
    PubMed     Abstract available


    October 2023
  7. FATTIZZO B, Gurnari C, Cassanello G, Bortolotti M, et al
    Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
    Leukemia. 2023 Oct 4. doi: 10.1038/s41375-023-02047.
    PubMed     Abstract available


    August 2023
  8. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
    Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
    Leukemia. 2023 Aug 25. doi: 10.1038/s41375-023-02011.
    PubMed    


  9. SEKERES MA, Montesinos P, Novak J, Wang J, et al
    Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.
    Leukemia. 2023 Aug 21. doi: 10.1038/s41375-023-02001.
    PubMed     Abstract available


    June 2023
  10. MARION W, Koppe T, Chen CC, Wang D, et al
    RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
    Leukemia. 2023 Jun 30. doi: 10.1038/s41375-023-01945.
    PubMed     Abstract available


  11. GALE RP, Hinterberger W, Young NS, Gennery AR, et al
    What causes aplastic anaemia?
    Leukemia. 2023;37:1191-1193.
    PubMed    


    May 2023
  12. NIKITIN E, Kislova M, Morozov D, Belyakova V, et al
    Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
    Leukemia. 2023 May 18. doi: 10.1038/s41375-023-01891.
    PubMed     Abstract available


    February 2023
  13. HUBER S, Haferlach T, Meggendorfer M, Hutter S, et al
    Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
    Leukemia. 2023;37:500-502.
    PubMed    


    October 2022
  14. PAGLIUCA S, Gurnari C, Hercus C, Hergalant S, et al
    Molecular landscape of immune pressure and escape in aplastic anemia.
    Leukemia. 2022 Oct 17. pii: 10.1038/s41375-022-01723.
    PubMed     Abstract available


    September 2022
  15. MESA R, Harrison C, Oh ST, Gerds AT, et al
    Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
    Leukemia. 2022;36:2261-2268.
    PubMed     Abstract available


    August 2022
  16. KELKKA T, Tyster M, Lundgren S, Feng X, et al
    Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.
    Leukemia. 2022 Aug 5. pii: 10.1038/s41375-022-01654.
    PubMed     Abstract available


    July 2022
  17. GROARKE EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, et al
    Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
    Leukemia. 2022 Jul 27. pii: 10.1038/s41375-022-01636.
    PubMed     Abstract available


    May 2022
  18. HUANG Y, Chen M, Yang C, Ruan J, et al
    Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
    Leukemia. 2022;36:1351-1360.
    PubMed     Abstract available


  19. KOMROKJI RS, Platzbecker U, Fenaux P, Zeidan AM, et al
    Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Leukemia. 2022;36:1432-1435.
    PubMed    


    April 2022
  20. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
    Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
    Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01549.
    PubMed     Abstract available


  21. SWOBODA DM, Kanagal-Shamanna R, Brunner AM, Cluzeau T, et al
    Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
    Leukemia. 2022;36:1189-1192.
    PubMed    


    January 2022
  22. LIN Q, Lian J, Wu J, Meng P, et al
    Erythropoietin receptor contributes to thrombopoietin receptor (Mpl)-independent thrombocytopoiesis in zebrafish.
    Leukemia. 2022 Jan 18. pii: 10.1038/s41375-021-01495.
    PubMed    


    October 2021
  23. ZHOU C, Kuang M, Liu Z, Jia X, et al
    Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.
    Leukemia. 2021 Oct 11. pii: 10.1038/s41375-021-01445.
    PubMed     Abstract available


    September 2021
  24. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 Sep 2. pii: 10.1038/s41375-021-01396.
    PubMed    


    August 2021
  25. FEURSTEIN S, Churpek JE, Walsh T, Keel S, et al
    Germline variants drive myelodysplastic syndrome in young adults.
    Leukemia. 2021;35:2439-2444.
    PubMed    


  26. GURNARI C, Pagliuca S, Patel BJ, Awada H, et al
    Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
    Leukemia. 2021;35:2431-2434.
    PubMed    


    June 2021
  27. GURNARI C, Durrani J, Pagliuca S, Kishtagari A, et al
    Novel invariant features of Good syndrome.
    Leukemia. 2021;35:1792-1796.
    PubMed    


    May 2021
  28. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 May 20. pii: 10.1038/s41375-021-01261.
    PubMed     Abstract available


    April 2021
  29. YOROIDAKA T, Hosokawa K, Imi T, Mizumaki H, et al
    Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
    Leukemia. 2021 Apr 6. pii: 10.1038/s41375-021-01202.
    PubMed     Abstract available


  30. ZHANG L, Chen JY, Kerr C, Cobb BA, et al
    Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Leukemia. 2021;35:1176-1187.
    PubMed     Abstract available


    March 2021
  31. LUNDGREN S, Keranen MAI, Kankainen M, Huuhtanen J, et al
    Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
    Leukemia. 2021 Mar 30. pii: 10.1038/s41375-021-01231.
    PubMed     Abstract available


  32. SEYFRIED AN, McCabe A, Smith JNP, Calvi LM, et al
    CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.
    Leukemia. 2021 Mar 20. pii: 10.1038/s41375-021-01219.
    PubMed     Abstract available


  33. FATTIZZO B, Ireland R, Dunlop A, Yallop D, et al
    Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Leukemia. 2021 Mar 4. pii: 10.1038/s41375-021-01190.
    PubMed     Abstract available


    November 2020
  34. SPORTOLETTI P, Sorcini D, Guzman AG, Reyes JM, et al
    Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Leukemia. 2020 Nov 6. pii: 10.1038/s41375-020-01075.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.